Brief: Hookipa Pharma Inc - On November 18 Approved Plan to Reduce Workforce By Approximately 80%
Nov 20 (Reuters) - HOOKIPA Pharma Inc HOOK.O :
* HOOKIPA PHARMA INC - ON NOVEMBER 18, CO APPROVED A PLANTO
REDUCE
WORKFORCE BY APPROXIMATELY 80%
* HOOKIPA PHARMA - RESTRUCTURING PLAN TO BEGIN IN Q4 2024,
COMPLETE BY H1 2025
* HOOKIPA PHARMA - TO PAUSE CLINICAL DEVELOPMENT IN
ESEBA-VEC
PROGRAM
* HOOKIPA PHARMA - EARLY TERMINATION OF HPV16+ TRIAL NOT DUE
TO
EFFICACY OR SAFETY
* HOOKIPA PHARMA INC: WILL FOCUS PRIMARILY ON PROGRESSING
THE
PHASE 1-READY HB-700 PROGRAM FOR THE TREATMENT OF KRAS MUTANT
CANCERS
Source text: [https://tinyurl.com/ye258tws]
Further company coverage: HOOK.O
Recent news on Hookipa Pharma
See all newsBrief: Hookipa Pharma Announces Sale Of Oncology Assets To Neotrail Therapeutics
Brief: Hookipa Pharma Announces Intention To Voluntarily Delist And Deregister Its Common Stock
Hookipa Pharma Inc Expected To Post A Loss Of $1.04 A Share: Earnings Preview
Brief: Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)